Docusign Inc (NASDAQ:DOCU) Director Enrique T. Salem Sells 49,245 Shares

Docusign Inc (NASDAQ:DOCU) Director Enrique T. Salem sold 49,245 shares of the business’s stock in a transaction dated Thursday, July 2nd. The shares were sold at an average price of $187.49, for a total value of $9,232,945.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Enrique T. Salem also recently made the following trade(s):

  • On Monday, July 6th, Enrique T. Salem sold 64,245 shares of Docusign stock. The shares were sold at an average price of $189.87, for a total value of $12,198,198.15.

DOCU opened at $206.35 on Thursday. The stock’s 50 day simple moving average is $155.43 and its 200 day simple moving average is $104.14. The stock has a market cap of $36.29 billion, a P/E ratio of -176.37 and a beta of 0.85. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.43 and a quick ratio of 1.43. Docusign Inc has a 1-year low of $43.13 and a 1-year high of $206.55.

Docusign (NASDAQ:DOCU) last announced its earnings results on Thursday, June 4th. The company reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.02. The firm had revenue of $297.02 million for the quarter, compared to analysts’ expectations of $281.12 million. Docusign had a negative return on equity of 29.36% and a negative net margin of 19.91%. Docusign’s quarterly revenue was up 38.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.07 EPS. Research analysts expect that Docusign Inc will post -0.74 EPS for the current fiscal year.

DOCU has been the subject of several analyst reports. Royal Bank of Canada upped their price objective on Docusign from $170.00 to $210.00 and gave the company an “outperform” rating in a research note on Thursday, July 2nd. JMP Securities upped their price objective on Docusign from $113.00 to $150.00 in a research note on Thursday, June 4th. Zacks Investment Research raised Docusign from a “hold” rating to a “strong-buy” rating and set a $147.00 price objective for the company in a research note on Friday, May 29th. Morgan Stanley upped their price objective on Docusign from $133.00 to $170.00 and gave the company an “equal weight” rating in a research note on Tuesday, June 23rd. Finally, Wedbush upped their price objective on Docusign from $140.00 to $165.00 and gave the company an “outperform” rating in a research note on Friday, June 5th. Seven research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Docusign currently has a consensus rating of “Buy” and a consensus target price of $135.68.

Institutional investors have recently modified their holdings of the business. Sunbelt Securities Inc. purchased a new position in shares of Docusign during the 4th quarter worth $2,242,000. Truvestments Capital LLC purchased a new position in shares of Docusign in the 1st quarter worth $25,000. Altshuler Shaham Ltd raised its position in shares of Docusign by 3,033.3% in the 1st quarter. Altshuler Shaham Ltd now owns 282 shares of the company’s stock worth $26,000 after buying an additional 273 shares during the period. Manchester Financial Inc. raised its position in shares of Docusign by 500.0% in the 1st quarter. Manchester Financial Inc. now owns 300 shares of the company’s stock worth $28,000 after buying an additional 250 shares during the period. Finally, Firestone Capital Management purchased a new position in shares of Docusign in the 1st quarter worth $32,000. 79.26% of the stock is currently owned by institutional investors.

Docusign Company Profile

DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.

Featured Story: Percentage Gainers

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.